Skip to main content

Latest stock market podcasts

From the helm: CSL's David Lamont on the biotech giant's bright future

Bell Direct
February 20, 2020

In the latest instalment of Bell Direct’s From the helm series, Jess has a chat with CSL’s CFO David Lamont. 

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 24 April

Sophia Mavridis
April 24, 2025

Morning Bell 23 April

Sophia Mavridis
April 23, 2025

Morning Bell 22 April

Sam Kanaan
April 22, 2025

Morning Bell 17 April

Bell Direct
April 17, 2025

Morning Bell 16 April

Bell Direct
April 16, 2025

Morning Bell 15 April

Bell Direct
April 15, 2025

Morning Bell 14 April

Bell Direct
April 14, 2025

Weekly Wrap 11 April

Bell Direct
April 11, 2025

Morning Bell 10 April

Bell Direct
April 10, 2025

Morning Bell 9 April

Bell Direct
April 9, 2025

Morning Bell 8 April

Bell Direct
April 8, 2025

Morning Bell 7 April

Bell Direct
April 7, 2025